Text Size

Site Search powered by Ajax

Zomig

Drug Name: Zomig

Drug ID: 402

Nutritional Considerations

  • Do not take this medication if you are unable to process the amino acid phenylalanine. Conversely, if you are currently taking the amino acid, phenylalanine, please be aware that this medication contains varying quantities of the amino acid, according to the milligram content of the medication. Each 2.5 mg and 5 mg ZOMIG-ZMTTM(zolmitriptan) Orally Disintegrating Tablet contains 2.81 mg and 5.62 mg of phenylalanine (a component of aspartame), respectively.

    1. ZOMIG® (zolmitriptan) and ZOMIG-ZMTTM (zolmitriptan) Orally Disintegrating Tablets, Prescribing Information, 05/01, AstraZeneca Pharmaceuticals LP, Wilmington, Delaware.
  • Tell your pharmacist or physician if you are taking the nutritional supplement 5-HTP.

    1. No reference available.

Herbal Considerations

  • Concurrent administration of MAO-A inhibitors or use of this medication within 2 weeks of discontinuation of MAO-A inhibitor therapy is contraindicated. This should include the herb St. John’s wort.

    1. ZOMIG® (zolmitriptan) and ZOMIG-ZMTTM (zolmitriptan) Orally Disintegrating Tablets, Prescribing Information, 05/01, AstraZeneca Pharmaceuticals LP, Wilmington, Delaware.

NDC Codes

00310021020, 00310021095, 00310021125, 00310021195